The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Organon & Co shares valued at $100,591 were purchased by COX CARRIE SMITH on May 14 ’25. At $8.07 per share, COX CARRIE SMITH acquired 12,469 shares. The insider’s holdings grew to 12,469 shares worth approximately $0.13 million following the completion of this transaction.
Also, Falcione Aaron purchased 5,500 shares, netting a total of over 48,235 in proceeds. Following the buying of shares at $8.77 each, the insider now holds 62,974 shares.
Before that, Weaver Kirke had added 8,045 shares to its account. In a trade valued at $74,054, the Gen. Counsel & Corp. Secy. bought Organon & Co shares for $9.21 each. Upon closing the transaction, the insider’s holdings increased to 8,045 shares, worth approximately $0.53 million.
As published in a research note from Evercore ISI on May 02, 2025, Organon & Co [OGN] has been rated down from an Outperform to an In-line. Analysts at JP Morgan downgraded the stock from ‘”a Neutral”‘ to ‘”an Underweight”‘ outlook in a report released in early September. As of November 03, 2023, Goldman has decreased its “Buy” rating to a “Neutral” for OGN. Earlier on September 21, 2023, Barclays initiated its rating. Their recommendation was “an Overweight” for OGN stock.
Analyzing OGN Stock Performance
On last trading session,, Organon & Co [NYSE: OGN] plunged -0.99% to $10.04. The stock’s lowest price that day was $10.025, but it reached a high of $10.38 in the same session. During the last five days, there has been a drop of approximately -0.59%. Over the course of the year, Organon & Co shares have dropped approximately -54.75%.
Support And Resistance Levels for Organon & Co (OGN)
RSI (Relative Strength Index) is 53.66 on the 14-day chart, showing neutral technical sentiment.
Is Organon & Co subject to short interest?
Stocks of Organon & Co saw a sharp steep in short interest on 2025-07-15 dropping by -1.26 million shares to 14.7 million. Data from Yahoo Finance shows that the short interest on 2025-06-13 was 15.95 million shares. A decline of -8.54% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 4.07 of the overall float, the days-to-cover ratio (short ratio) decline to 4.07.
Which companies own the most shares of Organon & Co (OGN)?
In terms of Organon & Co share price expectations, FactSet research, analysts set an average price target of 14 in the next 12 months, up nearly 38.07% from the previous closing price of $10.14. Analysts anticipate Organon & Co stock to reach 18 by 2025, with the lowest price target being 10. In spite of this, 3 analysts ranked Organon & Co stock as Buy at the end of 2025. On March 16, 2023, Raymond James assigned a price target of “an Outperform” to the stock and initiated coverage with a $33.
